Cholinergic adverse effects of cholinesterase inhibitors in Alzheimer's disease: epidemiology and management
S Gauthier - Drugs & aging, 2001 - Springer
Cholinergic adverse effects of acetylcholinesterase inhibitors (AChEIs) are caused by their
central and peripheral pharmacological actions on a variety of organ tissues …
central and peripheral pharmacological actions on a variety of organ tissues …
Cholinesterase inhibitors for the treatment of Alzheimer's disease:: getting on and staying on
GT Grossberg - Current Therapeutic Research, 2003 - Elsevier
Background: Cholinesterase (ChE) inhibitors currently used in the treatment of Alzheimer's
disease (AD) are the acetylcholinesterase (AChE)-selective inhibitors, donepezil and …
disease (AD) are the acetylcholinesterase (AChE)-selective inhibitors, donepezil and …
Rivastigmine in vascular dementia
R Moretti, P Torre, RM Antonello… - Expert Opinion on …, 2004 - Taylor & Francis
Patients with vascular dementia (VaD) show cholinergic deficits that may result in
characteristic clinical syndromes for different subtypes of the condition. Subcortical VaD is …
characteristic clinical syndromes for different subtypes of the condition. Subcortical VaD is …
Rivastigmine and Parkinson dementia complex
R Moretti, P Torre, C Vilotti, RM Antonello… - Expert opinion on …, 2007 - Taylor & Francis
Patients suffering from Parkinson's disease dementia (PDD) have a movement disorder, but
it can be difficult to determine whether the functional impairment, which is critical in making …
it can be difficult to determine whether the functional impairment, which is critical in making …
Management of Alzheimer's disease: defining the role of donepezil
T Ibbotson, KL Goa - Disease management and health outcomes, 2002 - Springer
Alzheimer's disease affects 15 million people worldwide. As the elderly population grows,
the incidence of Alzheimer's disease will also increase. It is estimated that by 2010, 40 …
the incidence of Alzheimer's disease will also increase. It is estimated that by 2010, 40 …